Filing Flows › Sanara MedTech (SMTI) › Q2 2026
Sanara MedTech (SMTI) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 11, 2026
Sanara MedTech (SMTI) reported revenue of $28.1M for the second quarter 2026 (Q2 2026), +9% from a year earlier and +1% from the quarter before. Operating margin was 6.3%, net loss $453K (1.6% of revenue).
Sanara MedTech, Q2 2026: revenue $28.1M (+9% year over year), operating margin 6.3%, net loss $453K, operating cash flow $2.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $28.1M | +1% | +9% |
| Operating profit | $1.8M | -33% | — |
| Net earnings | −$453K | -199% | — |
| Operating cash flow | $2.0M | — | -23% |
| Free cash flow | $2.0M | — | +125% |
What changed
Revenue was $28.1M in Q2 2026, up 9% year over year and up 1% from the previous quarter. Soft Tissue Repair Products was the largest line at 90% of revenue. Soft Tissue Repair Products added $2.6M year over year (up 11%), 111% of the total change. Bone Fusion Products declined 8%.
Gross margin was 93.0%, up 0.5 points from Q2 2025. Operating profit was $1.8M, a 6.3% margin (down 3.3 points year over year). Operating profit fell $707K even though revenue rose $2.3M versus Q2 2025, so costs grew faster than sales. Operating expenses grew 14% against revenue growth of 9%. The fastest-growing cost line was General & admin (+45%). The quarter ended with a net loss of $453K, after a profit of $459K the previous quarter. Net interest and other expense of $2.2M was the main reason.
Operating cash flow was $2.0M (down 23% year over year). Non-cash charges added back $619K of depreciation and amortization and $1.5M of share-based compensation. Working capital and other items added $376K. Capital expenditures of $5K left free cash flow of $2.0M.
Questions
What was Sanara MedTech's revenue in the second quarter 2026?
Sanara MedTech (SMTI) reported revenue of $28.1M for the second quarter 2026 (Q2 2026), +9% from a year earlier and +1% from the quarter before.
Was Sanara MedTech profitable in the second quarter 2026?
Operating profit was $1.8M (6.3% of revenue) and net loss $453K.
Source: Sanara MedTech 10-Q on SEC EDGAR.